F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.41M -18.99M -12.09M 4.74M -10.79M -15.65M -9.87M
Depreciation & Amortization
189K 154K 187K -607K 952K 153K 144K
Stock-Based Compensation
1.45M 1.42M 1.45M 1.34M 1.51M 1.86M 2.18M
Other Working Capital
-3.14M -1.1M -3.33M -581K -2.33M 5.45M -304K
Other Non-Cash Items
4.71M 1.97M 966K 902K 753K 919K -324K
Deferred Income Tax
n/a n/a n/a -569K n/a n/a n/a
Change in Working Capital
-4.49M -1.08M -2.13M 970K -3.14M 3.76M -6.51M
Operating Cash Flow
-16.55M -16.53M -11.62M 6.78M -10.71M -8.96M -14.38M
Capital Expenditures
-37K -235K n/a n/a n/a -391K -267K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
38K -121K n/a n/a n/a n/a 15K
Investing Cash Flow
1K -356K n/a n/a n/a -391K -252K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5K 303K 1.88M 1.05M 2K 87.05M n/a
Financial Cash Flow
5K 303K 1.88M 1.05M 2K 87.05M n/a
Net Cash Flow
-17.39M -15.84M -9.75M 7.5M -10.6M 77.97M -14.85M
Free Cash Flow
-16.59M -16.77M -11.62M 6.78M -10.71M -9.35M -14.64M